An integrated proteomics approach for studying the molecular pathogenesis of Dupuytren's disease

Journal of Pathology

Volumn 217, Issue 4, 2009, Pages 524-533

  Pavelic, Sandra Kraljevic ^a,b   Sedic, Mirela ^a   Hock, Karlo ^a   Vucinic, Srdan ^a   Jurisic, Davor ^c   Gehrig, Peter ^d   Scott, Mike ^d   Schlapbach, Ralph ^d   Cacev, Tamara ^a   Kapitanovic, Sanja ^a   Pavelic, Kresimir ^a,b  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b University of Rijeka   (Croatia)

^c KBC RIJEKA   (Croatia)

^d FUNCTIONAL GENOMICS CENTER ZURICH   (Switzerland)

Author keywords

Akt; Bioinformatics; Cytoskeleton; Dupuytren's disease; Proteomics

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; CYTOSKELETON PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; AUTOCRINE EFFECT; CELL METABOLISM; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; DUPUYTREN CONTRACTURE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MASS SPECTROMETRY; MOLECULAR BIOLOGY; OXIDATIVE STRESS; PALMAR FASCIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; BIOLOGY; CASE CONTROL STUDY; DNA MICROARRAY; FASCIA; GENE EXPRESSION PROFILING; HAND; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; COMPUTATIONAL BIOLOGY; CYTOSKELETAL PROTEINS; DUPUYTREN'S CONTRACTURE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FASCIA; GENE EXPRESSION PROFILING; HAND; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS;

EID: 62849116358     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2483     Document Type: Article

References (36)

1. Cordova A, Tripoli M, Corradino B, Napoli P, Moschella F. Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives. J Hand Surg (Br) 2005;30:557-562.
2. Hart MG, Hooper G. Clinical associations of Dupuytren's disease. Postgrad Med J 2005;81:425-428.
3. Murrell GA, Francis MJ, Bromley L. Modulation of fibroblast pro liferation by oxygen free radicals. Biochem J 1990;265:659-665.
4. Kraljevic S, Sedic M, Scott M, Gehrig P, Schlapbach R, Pavelic K. Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view? Cancer Treat Rev 2006;32:619-629.
5. Zhang D, Tai LK, Wong LL, Chiu LL, Sethi SK, Koay ES. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neupositive breast cancer. Mol Cell Proteomics 2005;4:1686-1696.
6. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probabilitybased protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999;20:3551-3567.
7. Rhodes DR, Tomlins SA, Varambally S, Mahavisno V, Bar rette T, Kalyana-Sundaram S, et al. Probabilistic model of the human protein-protein interaction network. Nature Biotechnol 2005;23:951-959.
8. von Mering C, Jensen LJ, Kuhn M, Chaffron S, Doerks T, Kruger B, et al. STRING 7 - recent developments in the integration and prediction of protein interactions. Nucleic Acids Res 2007;35:D358-D362.
9. Gire V, Roux P, Wynford-Thomas D, Brondello J, Dulic V. DNA damage checkpoint kinase Chk2 triggers replicative senescence. EMBO J 2004;23:2554-2563.
10. Ruhl M, Sahin E, Johannsen M, Somasundaram R, Manski D, Riecken EO, et al. Soluble collagen VI drives serum-starved fibroblasts through S phase and prevents apoptosis via downregulation of bax. J Biol Chem 1999;274:34361-34368.
11. Naugle JE, Olson ER, Zhang X, Mase SE, Pilati CF, Maron MB, et al. Type VI collagen induces cardiac myofibroblast differen tiation: implications for postinfarction remodeling. Am J Physiol Heart Circ Physiol 2006;290:H323-H330.
12. Kiely PA, Sant A, O'Connor R. RACK1 is an insulin-like growth factor 1 (IGF-1) receptor-interacting protein that can regulate IGF-1-mediated Akt activation and protection from cell death. J Biol Chem 2002;277:22581-22589.
13. Vandermoere F, El Yazidi-Belkoura I, Slomianny C, Demont Y, Bidaux G, Adriaenssens E, et al. The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J Biol Chem 2006;281:14307-14313.
14. Duthie RB, Francis MJ. Free radicals and Dupuytren's contracture. J Bone Jt Surg Br 1988;70:689-691.
15. Murrell GA, Francis MJ, Bromley L. Free radicals and Dupuytren's contracture. Br Med J (Clin Res Ed) 1987;295:1373-1375.
16. Lee SM, Koh HJ, Park DC, Song BJ, Huh TL, Park JW. Cytosolic NADP(+)-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 2002;32:1185-1196.
17. Neufer PD, Benjamin IJ. Differential expression of alpha-B- crystallin and Hsp27 in skeletal muscle during continuous contractile activity - relationship to myogenic regulatory factors. J Biol Chem 1996;271:24089-24095.
18. Nakamura M, Yamada M, Ohsawa T, Morisawa H, Nishine T, Nishimura O, et al. Phosphoproteomic profiling of human SH-SY5Y neuroblastoma cells during response to 6-hydroxydopamine-induced oxidative stress. Biochim Biophys Acta 2006;1763:977-989.
19. Goldring K, Jones GE, Thiagarajah R, Watt DJ. The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro. J Cell Sci 2002;115:355-366.
20. Delbruck A, Reimers E, Schonborn I. A comparative study of the activity of lysosomal and main metabolic pathway enzymes in tissue biopsies and cultured fibroblasts from Dupuytren's disease and palmar fascia. On the pathobiochemistry of connective tissue proliferation, I. J din Chem Clin Biochem 1981;19:931-941.
21. Bayat A, Walter J, Lambe H, Watson JS, Stanley JK, Marino M, et al. Identification of a novel mitochondrial mutation in Dupuytren's disease using multiplex DHPLC. Plast Reconstr Surg 2005;115:134-141.
22. Lu CY, Lee HC, Fahn HJ, Wei YH. Oxidative damage elicited by imbalance of free radical scavenging enzymes is associated with large-scale mtDNA deletions in aging human skin. Mutat Res 1999;423:11-21.
23. Liu S, Li J, Tao Y, Xiao X. Small heat shock protein alphaB-crystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis. Biochem Biophys Res Commun 2007;354:109-114.
24. Klein SD, Brune B. Heat-shock protein 70 attenuates nitric oxideinduced apoptosis in RAW macrophages by preventing cytochrome c release. Biochem J 2002;362:635-641.
25. Ravagnan L, Gurbuxani S, Susin SA, Maisse C, Daugas E, Zamzami N, et al. Heat-shock protein 70 antagonizes apoptosisinducing factor. Nature Cell Biol 2001;3:839-843.
26. Al-Qattan MM. Factors in the pathogenesis of Dupuytren's contracture. J Hand Surg (Am) 2006;31A:1527-1534.
27. Lamande SR, Morgelin M, Adams NE, Selan C, Allen JM. The C5 domain of the collagen VI alpha3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells. J Biol Chem 2006;281:16607-16614.
28. Lamande SR, Sigalas E, Pan TC, Chu ML, Dziadek M, Timpl R, et al. The role of the alpha3(VI) chain in collagen VI assembly. Expression of an alpha3(VI) chain lacking N-terminal modules N10-N7 restores collagen VI assembly, secretion, and matrix deposition in an alpha3(VI)-deficient cell line. J Biol Chem 1998;273:7423-7430.
29. Casalini P, Iorio MV, Galmozzi E, Menard S. Role of HER receptors family in development and differentiation. J Cell Physiol 2004;200:343- 350.
30. Vincent AM, Feldman EL. Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 2002;12:193-197.
31. Hermanto U, Zong CS, Li WQ, Wang LW. RACK1, an insulinlike growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact extracellular matrix. Mol Cell Biol 2002;22:2345-2365.
32. Kulik G, Klippel A, Weber MJ. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 1997;17:1595-1606.
33. Muller E, Castagnaro M, Yandel DW, Wolfe HJ, Alman BA. Molecular genetic and immunohistochemical analysis of the tumor suppressor genes Rb and P53 in palmar and aggressive fibromatosis. Diagn Mol Pathol 1996;5:194- 200.
34. Quasnichka H, Slater SC, Beeching CA, Boehm M, Sala-Newby GB, George SJ. Regulation of smooth muscle cell proliferation by beta-catenin/T-cell factor signaling involves modulation of cyclin D1 and p21 expression. Circ Res 2006;99:1329-1337.
35. Kim RH, Peters M, Jang Y, Shi W, Pintilie M, Fletcher GC, et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell 2005;7:263-273.
36. Kawai-Kowase K, Sato H, Oyama Y, Kanai H, Sato M, Doi H, et al. Basic fibroblast growth factor antagonizes transforming growth factor-beta 1-induced smooth muscle gene expression through extracellular signal-regulated kinase 1/2 signaling pathway activation. Arterioscler Thromb Vasc Biol 2004;24:1384-1390.